When was Zymeworks Inc. founded?
Zymeworks Inc. was founded in 2003.
Where are Zymeworks Inc. headquarters?
Zymeworks Inc. headquarters are in 540 - 1385 West 8th Ave, Vancouver, BC V6H 3V9, CA.
How many employees does Zymeworks Inc. have?
Zymeworks Inc. has 294 employees.
What sector does Zymeworks Inc. operate in?
Zymeworks Inc. is in Biotechnology Research sector.
What does Zymeworks Inc. Do ?
Zymeworks is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks’ mission is to make a meaningful difference in the lives of people impacted by difficult-to-treat cancers and other diseases. The Company’s complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates.Zymeworks engineered and developed zanidatamab, a HER2-targeted bispecific antibody using the Company’s proprietary Azymetric™ technology. Zymeworks has entered into separate agreements with BeiGene, Ltd. (BeiGene) and Jazz Pharmaceuticals Ireland Limited (Jazz), granting each exclusive rights to develop and commercialize zanidatamab in different territories. Zanidatamab is currently being evaluated in multiple global clinical trials as a potential best-in-class treatment for patients with HER2-expressing cancers. A Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the HER2-targeted bispecific antibody zanidatamab as a treatment for previously-treated, unresectable, locally advanced, or metastatic HER2-positive biliary tract cancer (BTC) has been submitted. If approved, zanidatamab would be the first HER2-targeted treatment specifically approved for BTC in the U.S.Zymeworks is rapidly advancing a deep pipeline of product candidates based on its experience and capabilities in both antibody-drug conjugates and multispecific antibody therapeutics across multiple novel targets in indications that represent areas of significant unmet medical need. In addition to Zymeworks’ wholly owned pipeline, its therapeutic platforms have been further leveraged through strategic partnerships with global biopharmaceutical companies.
What does Zymeworks Inc. specialize into ?
We are not able to find any specialities related to Zymeworks Inc. at the moment.
Who is the CEO of Zymeworks Inc. ?
We do not have the information about the CEO of Zymeworks Inc.. Our systems are trying to find it, we will update it as soon as we have it.
Try Mr. E's contact finder tool and fetch direct mobile numbers of decision-makers of all companies globally. Grow your sales now.
Free Trial with 5 contacts. No Credit Card Required. One-click Signup.